In addition, the NF2 LOF mutants promoted the NF2 KO IOMM-Lee xenograft tumor growth, while treatment with JNK inhibitor JNK-IN-8 significantly attenuated it (Fig. 7p, q). This evidence concerns the gene MAPK8 and neoplasm.